Skip navigation

4th Annual VA • DoD • PHS — Federal Pricing and Contracts for Bio/Pharmaceutical Companies

November 28-29, 2012
  • Philadelphia, Pennsylvania

Available for $298.00

Achieve Pricing and Contracting Excellence with the “Big Four” Federal Programs

The United States government commands tremendous power as a purchaser of bio/pharmaceutical drugs.  For manufacturers, providing lower cost drugs to the VA, DoD and PHS is a great opportunity that can be challenging to manage.  Understanding the Veterans Health Care Act and how it impacts Federal Supply Schedule Contracts, the Federal Ceiling Price and TRICARE Retail Pharmacy Program is critical to any manufacturer wishing to capitalize on this important and competitive market segment.  Pricing models and processes for complying with the complicated rules and regulations in this market are difficult for any manufacturer to master.

Join your industry colleagues to discuss:

  • HRSA’s Recertification of Entities
  • Section 863 and Its Affect on the Federal Supply Schedule  
  • Managing TRICARE Rebate Process Updates
  • Advanced Contracting and Pricing Strategies
  • Minimizing the Loss of Profitability